Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone If approved, cytisinicline will be the first new FDA-approved pharmacotherapy option for nicotine dependence in two decades More than 2,000 clinical trial participants contributed to the body of evidence submitted in the NDA demonstrating cytisinicline’s efficacy, safety, and tolerability profile SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life S ...

MIDLAND, Texas, June 26, 2025 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release second quarter 2025 financial results on August 4, 2025 after the market closes. In connection with the earnings release, Viper will host a conference call and webcast for investors and analysts to discuss its results for the second quarter of 2025 on Tuesday, August 5, 2025 at 10:00 a.m. CT. Access to ...

New York, June 26, 2025 (GLOBE NEWSWIRE) -- Kandal M Venture Limited (Nasdaq: FMFC) (the “Company”), a contract manufacturer of affordable luxury leather goods with manufacturing operations in Cambodia, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 Class A ordinary shares (the “Class A Ordinary Shares”) at a public offering price of $4.00 per share (the “Offering Price”). The Class A Ordinary Shares began trading on the Nasdaq Capital Market on June 25, 2025, under ...

Core Points - Tree Island Steel Ltd. announced that all matters at its 2025 Annual General Meeting of Shareholders received requisite shareholder approval [1] - The company elected all six director nominees proposed by management, with a total of 17,117,784 shares represented, accounting for approximately 65.85% of outstanding shares [2] Board of Directors - The voting results for the director elections showed high approval rates for all nominees, with Sam Fleiser receiving 99.86% votes in favor, while other nominees received between 96.18% and 96.32% [2] - The detailed voting results for each nominee are as follows: - Amar S. Doman: 16,397,252 votes for (96.18%), 651,793 votes against (3.82%) [2] - Peter Bull: 16,421,214 votes for (96.32%), 627,831 votes against (3.68%) [2] - Sam Fleiser: 17,025,005 votes for (99.86%), 24,040 votes against (0.14%) [2] - Joe Downes: 16,421,214 votes for (96.32%), 627,831 votes against (3.68%) [2] Company Overview - Tree Island Steel, headquartered in Richmond, British Columbia, has been operational since 1964 and produces a variety of wire products for industrial, residential, commercial, and agricultural applications [3] - The company's product offerings include galvanized wire, bright wire, fasteners, stucco reinforcing products, concrete reinforcing mesh, fencing, and other fabricated wire products, marketed under various brand names [3]

Vancouver, BC, June 26, 2025 (GLOBE NEWSWIRE) -- Oxley Bridge Acquisition Limited (the “Company”) announced today the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000. The Company’s units began trading on June 25, 2025 on The Nasdaq Global Stock Market LLC (“Nasdaq”) under the ticker symb ...

Core Viewpoint - INmune Bio Inc. is set to present top line data from the Phase 2 MINDFuL trial focused on early Alzheimer's Disease during a conference call on June 30, 2025 [1][2]. Group 1: MINDFuL Trial Details - The MINDFuL trial is an international, blinded, randomized Phase 2 study involving patients with early Alzheimer's Disease (AD) who exhibit biomarkers of elevated neuroinflammation [3]. - Participants in the trial must have at least one of four inflammation biomarkers: elevated CRP, HgbA1c, ESR, or ApoE4 allele, and they receive either XPro™ or placebo in a 2:1 ratio for 6 months [3]. - Cognitive endpoints for the trial include EMACC and CDR, with XPro™ administered as a once-a-week subcutaneous injection [3]. Group 2: XPro™ Overview - XPro™ is a next-generation inhibitor of tumor necrosis factor (TNF) that selectively neutralizes soluble TNF without affecting trans-membrane TNF or TNF receptors [4]. - The drug aims to reduce neuroinflammation, potentially benefiting patients with neurological diseases [4]. Group 3: Company Background - INmune Bio Inc. is a publicly traded clinical-stage biotechnology company focused on developing treatments targeting the innate immune system [5]. - The company has three product platforms, including the Dominant-Negative Tumor Necrosis Factor (DN-TNF) platform, which is in clinical trials for Mild Alzheimer's disease, Mild Cognitive Impairment, and treatment-resistant depression [5][6]. - Other platforms include the Natural Killer Cell Priming Platform and the CORDStrom™ program, which targets chronic inflammation and cancer [5][6].

Company believes it has regained compliance with pro forma net equity of approximately US$20 million as of May 31, 2025 US$121 million Reg S investment round led by His Royal Highness Prince Abdulaziz bin Turki bin Talal Al Saud Including binding close of first-phase private placement totalling US$60.5 million in gross proceeds LONDON, June 26, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) (“VivoPower” or the “Company”) is pleased to announce that, based on a binding close of the first ...

Core Viewpoint - Tribe Property Technologies Inc. is initiating a public offering of units at an issue price of $0.45 per unit, aiming for gross proceeds of up to $5 million, with each unit consisting of one common share and one-half of a warrant [1][4] Group 1: Offering Details - The offering will be conducted on a "best efforts" agency basis, led by Raymond James Ltd. [2] - The agents will have an option to sell up to 15% additional units to cover over-allotments, exercisable within 30 days post-closing [3] - The expected closing date for the offering is around July 7, 2025, subject to customary closing conditions and necessary approvals [4] Group 2: Use of Proceeds - Net proceeds from the offering will be allocated for growth initiatives, including technology investments, potential acquisitions, working capital, and vendor repayments [4] Group 3: Company Overview - Tribe Property Technologies is a property technology company aiming to disrupt the traditional property management industry through a tech-forward approach [8] - The company focuses on acquiring accretive targets in the North American property management sector and enhancing operations through digitization [8] - Tribe's platform aims to reduce customer acquisition costs, improve retention, and offer value-added products and services [9]

Group 1 - Independent Bank Corporation (NASDAQ: IBCP) will release its 2025 second quarter results on July 24, 2025, at approximately 8:00 am ET [1] - A conference call for investors and analysts will be held on the same day at 11:00 am ET, featuring President and CEO Brad Kessel, CFO Gavin Mohr, and EVP Commercial Banking Joel Rahn [2] - The conference call can be accessed via phone or an audio webcast, with a playback option available until July 31, 2025 [3] Group 2 - Independent Bank Corporation is a Michigan-based bank holding company with total assets of approximately $5.3 billion [4] - The company operates a branch network across Michigan's Lower Peninsula and offers a full range of financial services, including commercial banking, mortgage lending, investments, insurance, and title services [4] - Independent Bank Corporation emphasizes exceptional personal service and value to its customers, stockholders, and communities [4]

Core Viewpoint - Critical One Energy Inc. has successfully closed a non-brokered financing, raising CDN$1,000,000 through the issuance of 2,500,000 units at CDN$0.40 per unit, which will be utilized for exploration activities and general expenses [1][4]. Financing Details - The financing involved the issuance of units, each consisting of one common share and one-half common share purchase warrant, with full warrants allowing the purchase of one common share at CDN$0.60 for 18 months [2]. - A director participated in the financing, acquiring 230,000 units for a total of CDN$92,000, qualifying as a related party transaction [2][3]. Regulatory Compliance - The company relied on exemptions from valuation and minority approval requirements under Multilateral Instrument 61-101, as the transaction did not exceed 25% of the company's market capitalization [3]. Use of Proceeds - Proceeds from the private placement are earmarked for exploration activities at the Howells Lake Antimony Gold Project and for general administrative expenses [4]. Company Overview - Critical One Energy Inc. focuses on critical minerals and upstream energy, with a strategic position to meet the rising global demand for critical minerals, particularly through its antimony-gold exploration in Canada and uranium interests in Namibia [5].